BIOVIE ($BIVI) posted quarterly earnings results for Q3 2026 on Monday, May 11th. The company reported earnings of -$0.70 per share, beating estimates of -$0.74 by $0.04. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $BIVI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOVIE Hedge Fund Activity
We have seen 13 institutional investors add shares of BIOVIE stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PROSPERITY WEALTH MANAGEMENT, INC. removed 143,500 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $166,460
- DRW SECURITIES, LLC added 128,356 shares (+inf%) to their portfolio in Q4 2025, for an estimated $148,892
- CITADEL ADVISORS LLC removed 86,381 shares (-82.6%) from their portfolio in Q4 2025, for an estimated $100,201
- VANGUARD GROUP INC added 84,599 shares (+65.6%) to their portfolio in Q4 2025, for an estimated $98,134
- PRELUDE CAPITAL MANAGEMENT, LLC removed 52,699 shares (-36.4%) from their portfolio in Q4 2025, for an estimated $61,130
- RENAISSANCE TECHNOLOGIES LLC removed 44,900 shares (-61.6%) from their portfolio in Q4 2025, for an estimated $52,084
- MORGAN STANLEY added 29,925 shares (+98.8%) to their portfolio in Q4 2025, for an estimated $34,713
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
